“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”
In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind
NCI Budget for FY 1977 Would Halt New Research
Congressman Obey Attacks NCI for Not Supporting Basic Research
Nutrition RFPs Will Really Be Grants, Gori Says
Cyclamate Committee Finds No Proof Of Carcinogenicity
Trending Stories
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center









